Migraine Treatment in Spontaneous Coronary Artery Dissection (SCAD)

Introduction to SCAD and Migraine

The European Heart Journal recommends that for patients with SCAD, non-vasoconstrictive migraine treatments should be prioritized, avoiding triptans and using CGRP inhibitors with caution due to potential cardiovascular risks 1, 2
SCAD is a non-atherosclerotic separation of coronary arterial layers creating a false lumen and downstream myocardial ischemia, occurring predominantly in women under 60 years (22-35% of ACS cases in this demographic) 1, 3, 4

SCAD affects women in over 90% of cases, according to the European Heart Journal 6
SCAD is often precipitated by emotional or physical stress, as reported in the European Heart Journal 6
SCAD is associated with fibromuscular dysplasia in up to 72% of cases, as noted in the European Heart Journal 6
There is a higher prevalence of SCAD in patients with a history of anxiety, depression, or previous neuropsychiatric disorders, as stated in the European Heart Journal 2

The European Heart Journal strongly recommends beta-blockers as they reduce the risk of recurrent SCAD while also providing migraine prophylaxis 2
The European Heart Journal recommends aggressive blood pressure control using anti-hypertensive medications, as hypertension is an independent predictor of recurrent SCAD 1

Stress management techniques are recommended, as SCAD is often precipitated by stress, according to the European Heart Journal 6
Regular sleep schedule and adequate hydration are advised, although the specific citation for this is from Praxis Medical Insights, the European Heart Journal also emphasizes the importance of lifestyle modifications in managing SCAD and migraines 5, 6

SCAD patients with migraines should be monitored closely, as both conditions can recur, as recommended by the European Heart Journal and Praxis Medical Insights 1, 2, 5